News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
By Fiona BARRY
- Last updated on
BeiGene has appointed ex-Roche director Zhengming Du as senior VP and head of chemistry and manufacturing controls.
The Chinese biopharma produces small molecule and monoclonal antibody cancer therapies.
“Dr Du is very talented and a strong addition to our manufacturing team I’m delighted to have him join BeiGene,” said John Oyler, CEO of BeiGene.
“Dr Du has over 30 years of academic and pharmaceutical R&D experience, and his proven track record in leadership and execution makes him the ideal choice to lead our CMC strategies to support commercial development of our pre-clinical and clinical assets in our portfolio.”
Dr Du joins BeiGene from Roche Pharmaceuticals in China, where he was the director and head of process research and synthesis. He previously held senior chemistry roles at Zhejiang Huahai Pharmaceuticals and Novartis.